Skip to main content

Advertisement

SpringerLink
Log in

Significant response of pituitary carcinoma to carboplatin, leucovorin and fluorouracil chemotherapy: a pediatric case report and review of the literature

  • Letter to the Editor
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Heaney AP (2011) Pituitary carcinoma: difficult diagnosis and treatment. J Clin Endocrinol Metab 12:3649–3660

    Article  Google Scholar 

  2. Lim S, Shahinian H, Maya M et al (2006) Temozolamide: a novel treatment for pituitary carcinoma. Lancet Oncol 7:518–520

    Article  PubMed  Google Scholar 

  3. Dworakowska D, Wlodek E, Leontiou CA (2009) Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors. Endocr Relat Cancer 16:1329–1338

    Article  CAS  PubMed  Google Scholar 

  4. McCabe CJ, Boelaert K, Tannahill LA (2002) Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab 87:4238–4244

    Article  CAS  PubMed  Google Scholar 

  5. Jouanneau E, Wierinckx A, Ducray F (2012) New targeted therapies in pituitary carcinoma resistant to temozolomide. Pituitary 15:37–43

    Article  CAS  PubMed  Google Scholar 

  6. Oritz LD, Syro LV, Scheithauer BW (2011) Anti-VEGF therapy in pituitary carcinoma. Pituitary 15:445–449

    Article  Google Scholar 

Download references

Funding

There was no funding for this work.

Author information

Authors and Affiliations

  1. Hematology-Oncology Division, Nationwide Children’s Hospital, The Ohio State University, 700 Children’s drive, Columbus, OH, 43205, USA

    Mohamed S. AbdelBaki

  2. Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Steven G. Waguespack

  3. Hospital Civil de Guadalajara, Universidad de Guadalajara, Guadalajara, Mexico

    Violeta Salceda

  4. Division of Diagnostic Radiology, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX, USA

    Jeremy Jones

  5. Cancer and Blood Disorder Institute, Johns Hopkins All Children’s Hospital, St. Petersburg, FL, USA

    Stacie L. Stapleton

  6. Department of Neurosurgery, Houston Methodist Hospital, Kenneth R. Peak Brain and Pituitary Treatment Center, Houston, TX, USA

    David S. Baskin

  7. Department of Pediatrics, Hematology-Oncology, Texas Children’s Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, USA

    M. Fatih Okcu

Authors
  1. Mohamed S. AbdelBaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven G. Waguespack
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Violeta Salceda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jeremy Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stacie L. Stapleton
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David S. Baskin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Fatih Okcu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohamed S. AbdelBaki.

Ethics declarations

Conflict of interest

All the authors declare no conflicts of interest.

Informed consent

Informed consent for treatment with surgery and chemotherapy was obtained from all individual participants included in the study.

Research involving human participants and/or animals

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

AbdelBaki, M.S., Waguespack, S.G., Salceda, V. et al. Significant response of pituitary carcinoma to carboplatin, leucovorin and fluorouracil chemotherapy: a pediatric case report and review of the literature. J Neurooncol 135, 213–215 (2017). https://doi.org/10.1007/s11060-017-2554-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-017-2554-1

Search

Navigation